Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders (Snoring)

This study has been withdrawn prior to enrollment.

(The BfArM (CA)approved the trial in Nov 2008. However, the responsible EC refused approval in March 2009.)

Sponsor:

Information provided by:

Merz Pharmaceuticals GmbH

ClinicalTrials.gov Identifier:

NCT00773591

First received: October 15, 2008

Last updated: August 9, 2010

Last verified: August 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	October 2010
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)